Up-regulation of TNF-alpha secretion by cigarette smoke is mediated by Egr-1 in HaCaT human keratinocytes

Experimental Dermatology

Volumn 19, Issue 8, 2010, Pages

  Jeong, Sang Hoon ^a   Park, Jae Hong ^a   Kim, Ji Na ^a   Park, Yoon Hee ^a   Shin, Soon Young ^b   Lee, Young Han ^b   Kye, Young Chul ^a   Son, Sang Wook ^a  

^a Korea University College of Medicine   (South Korea)

^b Konkuk University   (South Korea)

Author keywords

Cigarette smoke; Egr 1; Psoriasis; TNF alpha

Indexed keywords

CIGARETTE SMOKE; EARLY GROWTH RESPONSE FACTOR 1; MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CYTOTOXICITY; HUMAN; HUMAN CELL; KERATINOCYTE; PROTEIN EXPRESSION; PROTEIN SECRETION; UPREGULATION;

CELL LINE; CELL SURVIVAL; EARLY GROWTH RESPONSE PROTEIN 1; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; KERATINOCYTES; MAP KINASE KINASE 4; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SMOKING; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 77954853507     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2009.01050.x     Document Type: Article

References (45)

1. Lowes M A, Bowcock A M, Krueger J G. Pathogenesis and therapy of psoriasis. Nature 2007, 445:866-873.
2. Naldi L, Chatenoud L, Linder D. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. J Invest Dermatol 2005, 125:61-67.
3. Herron M D, Hinckley M, Hoffman M S. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol 2005, 141:1527-1534.
4. Huerta C, Rivero E, Rodriguez L A. Incidence and risk factors for psoriasis in the general population. Arch Dermatol 2007, 143:1559-1565.
5. Richter-Hintz D, Their R, Steinwachs S. Allelic variants of drug metabolizing enzymes as risk factors in psoriasis. J Invest Dermatol 2003, 120:765-770.
6. Yen J H, Tsai W C, Lin C H, Ou T T, Hu C J, Liu H W. Cytochrome p450 1Al gene polymorphisms in patients with psoriatic arthritis. Scand J Rheumatol 2004, 33:19-23.
7. Barker J N, Mitra R S, Griffiths C E, Dixit V M, Nickoloff B J. Keratinocytes as initiators of inflammation. Lancet 1991, 337:211-214.
8. Lisby S, Hauser C. Transcriptional regulation of tumor necrosis factor-alpha in keratinocytes mediated by interleukin-1beta and tumor necrosis factor-alpha. Exp Dermatol 2002, 11:592-598.
9. Mossner R, Schon M P, Reich K. Tumor necrosis factor antagonists in the therapy of psoriasis. Clin Dermatol 2008, 26:486-502.
10. Sukhatme V P. Early transcriptional events in cell growth: the Egr family. J Am Soc Nephrol 1990, 1:859-866.
11. Lim R W, Varnum B C, Herschman H R. Cloning of tetradecanoyl phorbol ester-induced 'primary response' sequences and their expression in density-arrested Swiss 3T3 cells and a TPA non-proliferative variant. Oncogene 1987, 1:263-270.
12. Christy B A, Lau L F, Nathans D. A gene activated in mouse 3T3 cells by serum growth factors encodes a protein with " zinc finger" sequences. Proc Natl Acad Sci U S A 1988, 85:7857-7861.
13. Sukhatme V P, Cao X M, Chang L C. A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell 1988, 53:37-43.
14. Khachigian L M, Lindner V, Williams A J, Collins T. Egr-1-induced endothelial gene expression: a common theme in vascular injury. Science 1996, 271:1427-1431.
15. McMahon S B, Monroe J G. The role of early growth response gene 1 (egr-1) in regulation of the immune response. J Leukoc Biol 1996, 60:159-166.
16. Harja E, Bucciarelli L G, Lu Y. Early growth response-1 promotes atherogenesis: mice deficient in early growth response-1 and apolipoprotein E display decreased atherosclerosis and vascular inflammation. Circ Res 2004, 94:333-339.
17. Gong L B, He L, Liu Y, Chen X Q, Jiang B. Expression of early growth response factor-1 in rats with cerulein-induced acute pancreatitis and its significance. World J Gastroenterol 2005, 11:5022-5024.
18. Mark E B, Jonsson M, Asp J, Wennberg A M, Molne L, Lindahl A. Expression of genes involved in the regulation of p16 in psoriatic involved skin. Arch Dermatol Res 2006, 297:459-467.
19. Fang M, Wee S A, Ronski K, Fan H, Tao S, Lin Q. Evidence of EGR1 as a differentially expressed gene among proliferative skin diseases. Genomic Med 2007, 1:75-85.
20. Ishii T, Matsuse T, Igarashi H, Masuda M, Teramoto S, Ouchi Y. Tobacco smoke reduces viability in human lung fibroblasts: protective effect of glutathione S-transferase P1. Am J Physiol Lung Cell Mol Physiol 2001, 280:L1189-L1195.
21. Reynolds P R, Cosio M G, Hoidal J R. Cigarette smoke-induced Egr-1 upregulates proinflammatory cytokines in pulmonary epithelial cells. Am J Respir Cell Mol Biol 2006, 35:314-319.
22. Ning W, Dong Y, Sun J. Cigarette smoke stimulates matrix metalloproteinase-2 activity via EGR-1 in human lung fibroblasts. Am J Respir Cell Mol Biol 2007, 36:480-490.
23. Khachigian L M, Collins T. Inducible expression of Egr-1-dependent genes. A paradigm of transcriptional activation in vascular endothelium. Circ Res 1997, 81:457-461.
24. Khokhlatchev A V, Canagarajah B, Wilsbacher J. Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation. Cell 1998, 93:605-615.
25. Roux P P, Blenis J. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 2004, 68:320-344.
26. Al-Sarraj A, Thiel G. The zinc finger transcription factor Egr-1 is upregulated in arsenite-treated human keratinocytes. J Mol Med 2004, 82:530-538.
27. Kishore R, Hill J R, McMullen M R, Frenkel J, Nagy L E. ERK1/2 and Egr-1 contribute to increased TNF-alpha production in rat Kupffer cells after chronic ethanol feeding. Am J Physiol Gastrointest Liver Physiol 2002, 282:G6-G15.
28. Li C J, Ning W, Matthay M A, Feghali-Bostwick C A, Choi A M. MAPK pathway mediates EGR-1-HSP70-dependent cigarette smoke-induced chemokine production. Am J Physiol Lung Cell Mol Physiol 2007, 292:L1297-L1303.
29. Johansen C, Kragballe K, Westergaard M, Henningsen J, Kristiansen K, Iversen L. The mitogen-activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin. Br J Dermatol 2005, 152:37-42.
30. Kuschner W G, D'Alessandro A, Wong H, Blanc P D. Dose-dependent cigarette smoking-related inflammatory responses in healthy adults. Eur Respir J 1996, 9:1989-1994.
31. Uyemura K, Yamamura M, Fivenson D F, Modlin R L, Nickoloff B J. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol 1993, 101:701-705.
32. Ettehadi P, Greaves M W, Wallach D, Aderka D, Camp R D. Elevated tumour necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions. Clin Exp Immunol 1994, 96:146-151.
33. Guha M, O'Connell M A, Pawlinski R. Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression. Blood 2001, 98:1429-1439.
34. Shi L, Kishore R, McMullen M R, Nagy L E. Lipopolysaccharide stimulation of ERK1/2 increases TNF-alpha production via Egr-1. Am J Physiol Cell Physiol 2002, 282:C1205-C1211.
35. Son S W, Min B W, Lim Y, Lee Y H, Shin S Y. Regulatory mechanism of TNFalpha autoregulation in HaCaT cells: the role of the transcription factor EGR-1. Biochem Biophys Res Commun 2008, 374:777-782.
36. Totti N, McCusker K T, Campbell E J, Griffin G L, Senior R M. Nicotine is chemotactic for neutrophils and enhances neutrophil responsiveness to chemotactic peptides. Science 1984, 223:169-171.
37. Aicher A, Heeschen C, Mohaupt M, Cooke J P, Zeiher A M, Dimmeler S. Nicotine strongly activates dendritic cell-mediated adaptive immunity: potential role for progression of atherosclerotic lesions. Circulation 2003, 107:604-611.
38. Martin J W, Mousa S S, Shaker O, Mousa S A. The multiple faces of nicotine and its implications in tissue and wound repair. Exp Dermatol 2009, 18:497-505.
39. Thomas G A, Rhodes J, Ingram J R. Mechanisms of disease: nicotine - a review of its actions in the context of gastrointestinal disease. Nat Clin Pract Gastroenterol Hepatol 2005, 2:536-544.
40. Gottipati K R, Poulsen H, Starcher B. Passive cigarette smoke exposure inhibits ultraviolet light B-induced skin tumors in SKH-1 hairless mice by blocking the nuclear factor kappa B signalling pathway. Exp Dermatol 2008, 17:780-787.
41. Ichino N, Yamada K, Nishii K, Sawada H, Nagatsu T, Ishiguro H. Increase of transcriptional levels of egr-1 and nur77 genes due to both nicotine treatment and withdrawal in pheochromocytoma cells. J Neural Transm 2002, 109:1015-1022.
42. Nickoloff B J. Cracking the cytokine code in psoriasis. Nat Med 2007, 13:242-244.
43. Kock A, Schwarz T, Kirnbauer R. Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med 1990, 172:1609-1614.
44. Grone A. Keratinocytes and cytokines. Vet Immunol Immunopathol 2002, 88:1-12.
45. Kaufmann K, Thiel G. Epidermal growth factor and thrombin induced proliferation of immortalized human keratinocytes is coupled to the synthesis of Egr-1, a zinc finger transcriptional regulator. J Cell Biochem 2002, 85:381-391.